Showing 1 - 12 results of 12 for search 'Naveen K Mehta', query time: 0.03s Refine Results
  1. 1
    ENGLISH NEWSPAPERS: EXPLORING INNOVATIVE METHODOLOGICAL PARADIGM (A STUDY INTO CLASSROOM DYNAMICS)

    ENGLISH NEWSPAPERS: EXPLORING INNOVATIVE METHODOLOGICAL PARADIGM (A STUDY INTO CLASSROOM DYNAMICS) by NAVEEN K MEHTA

    Published 2010-06-01
    Get full text
    Article
  2. 2
    A Study of Customer Relationship Management Practices in Madhya Pradesh State Tourism Services

    A Study of Customer Relationship Management Practices in Madhya Pradesh State Tourism Services by Dharmendra MEHTA, Jitendra K. SHARMA, Naveen K. MEHTA

    Published 2010-05-01
    Get full text
    Article
  3. 3
    A Study of Customer Relationship Management Practices in Madhya Pradesh State Tourism Services

    A Study of Customer Relationship Management Practices in Madhya Pradesh State Tourism Services by Dharmendra MEHTA, Jitendra K. SHARMA, Naveen K. MEHTA

    Published 2010-05-01
    Get full text
    Article
  4. 4
    An Exploratory Study on Implementation of Lean Manufacturing Practices(With Special Reference to Automobile Sector Industry)(Yalın İmalat Faaliyetine Yönelik Bir Uygulama (Otomobil Endüstrisi Örneği)

    An Exploratory Study on Implementation of Lean Manufacturing Practices(With Special Reference to Automobile Sector Industry)(Yalın İmalat Faaliyetine Yönelik Bir Uygulama (Otomobil... by Er. Rajesh Kumar MEHTA, Dhermendra MEHTA, Naveen K. MEHTA

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors

    Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors by Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, Alexander Steinle, Jennifer S. Michaelson, Patrick A. Baeuerle

    Published 2023-12-01
    Get full text
    Article
  6. 6
    Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models

    Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models by Adrienne Rothschilds, Alice Tzeng, Naveen K. Mehta, Kelly D. Moynihan, Darrell J. Irvine, K. Dane Wittrup

    Published 2019-05-01
    Get full text
    Article
  7. 7
    1024 CLN-978, a novel CD19/CD3/HSA T cell engager with extended serum half-life, is effective against lymphoma cells expressing very low levels of CD19

    1024 CLN-978, a novel CD19/CD3/HSA T cell engager with extended serum half-life, is effective against lymphoma cells expressing very low levels of CD19 by Agapitos Patakas, Naveen K Mehta, Patrick A Baeuerle, Jennifer S Michaelson, Kristan A Meetze, Hannah M Findlay, Timothy B London

    Published 2023-11-01
    Article
  8. 8
    CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression

    CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression by Agapitos Patakas, Bochong Li, Naveen K Mehta, Kristan Meetze, Patrick A Baeuerle, Jennifer S Michaelson, Hannah M Findlay, Timothy B London

    Published 2023-08-01
    Get full text
    Article
  9. 9
    1093 CLN-617 combines IL-2 and IL-12 in a single molecule to optimally balance safety and efficacy upon intratumoral injection

    1093 CLN-617 combines IL-2 and IL-12 in a single molecule to optimally balance safety and efficacy upon intratumoral injection by Naveen K Mehta, Patrick A Baeuerle, Jennifer S Michaelson, Laura Liu, K Dane Wittrup, Kristan A Meetze, Irina M Shapiro, Kavya Rakhra

    Published 2023-11-01
    Article
  10. 10
    1171 CLN-418, a clinical-stage B7H4 x 4–1BB bispecific antibody with potential to treat patients with a wide range of solid tumors

    1171 CLN-418, a clinical-stage B7H4 x 4–1BB bispecific antibody with potential to treat patients with a wide range of solid tumors by Yun He, Ella Ioffe, Bing Huang, Naveen K Mehta, Patrick A Baeuerle, Jennifer S Michaelson, Kristan A Meetze, Irina M Shapiro, Hanna Dobrowolska

    Published 2023-11-01
    Article
  11. 11
    771 A phase 1 study to assess safety, efficacy, pharmacokinetics, and pharmacodynamics of intratumoral CLN-617 (IL2/IL12 fusion protein) combined with pembrolizumab in patients with advanced solid tumors

    771 A phase 1 study to assess safety, efficacy, pharmacokinetics, and pharmacodynamics of intratumoral CLN-617 (IL2/IL12 fusion protein) combined with pembrolizumab in patients wit... by Evan Hall, Adi Diab, Sajeve Thomas, Randy Sweis, Anthony El-Khoueiry, Naveen K Mehta, Jennifer S Michaelson, Laura Liu, Reham Abdel-Wahab, Jeffrey A Jones, Kaida Wu, Benjamin S Maciejewski

    Published 2023-11-01
    Article
  12. 12
    A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL

    A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL by Melanie Märklin, Gundram Jung, Jonas S Heitmann, Joseph Kauer, Helmut R Salih, Stefanie Mueller, Bochong Li, Latifa Zekri, Naveen K Mehta, Martin Pfluegler, Kristan Meetze, Isabelle Sindel, Fabian Vogt, Lukas Osburg, Hans-Jörg Bühring, Sebastian Hörner, Patrick A Baeuerle, Jennifer S Michaelson

    Published 2022-03-01
    Get full text
    Article

Search Tools: